AUTL vs CLOV · rev $10.1M vs rev $1.37B
Autolus Therapeutics Ltd (AUTL) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AUTL revenue for 2024-12-31 was $10.1M. Net income was -$220.7M. Revenue was up 496.0% from 2023-12-31 to 2024-12-31. AUTL currently screens at market cap $614.8M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AUTL currently screens at market cap $614.8M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AUTL and CLOV stock pages for the full models.
Not investment advice.